Aquilo Capital Management as of Sept. 30, 2019
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 10 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 26.9 | $38M | 500k | 76.25 | |
| Uniqure Nv (QURE) | 21.9 | $31M | 791k | 39.36 | |
| Merus N V (MRUS) | 13.0 | $19M | 1.0M | 17.82 | |
| Spero Therapeutics (SPRO) | 8.6 | $12M | 1.2M | 10.60 | |
| Pieris Pharmaceuticals | 7.1 | $10M | 3.0M | 3.41 | |
| Bicycle Therapeutics (BCYC) | 6.2 | $8.7M | 767k | 11.39 | |
| Galapagos Nv- (GLPG) | 6.1 | $8.7M | 57k | 152.66 | |
| Xenon Pharmaceuticals (XENE) | 6.0 | $8.6M | 952k | 9.01 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 3.4 | $4.8M | 832k | 5.76 | |
| Fate Therapeutics (FATE) | 0.8 | $1.1M | 72k | 15.52 |
